Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14535311
[patent_doc_number] => 20190203277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => CRISSCROSS COOPERATIVE SELF-ASSEMBLY
[patent_app_type] => utility
[patent_app_number] => 16/322787
[patent_app_country] => US
[patent_app_date] => 2017-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18273
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322787
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/322787 | Crisscross cooperative self-assembly | Aug 1, 2017 | Issued |
Array
(
[id] => 12791860
[patent_doc_number] => 20180155789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CEP290-ASSOCIATED DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/667603
[patent_app_country] => US
[patent_app_date] => 2017-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 119581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15667603
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/667603 | Compositions and methods for treating CEP290-associated disease | Aug 1, 2017 | Issued |
Array
(
[id] => 12238475
[patent_doc_number] => 20180071338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'PROGRESSIVELY TUMORIGENIC CELL LINES'
[patent_app_type] => utility
[patent_app_number] => 15/664305
[patent_app_country] => US
[patent_app_date] => 2017-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15820
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15664305
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/664305 | Progressively tumorigenic cell lines | Jul 30, 2017 | Issued |
Array
(
[id] => 17090030
[patent_doc_number] => 11118210
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Genetically engineered gas vesicle gene clusters, genetic circuits, vectors, prokaryotic cells, compositions, methods and systems for contrast-enhanced imaging
[patent_app_type] => utility
[patent_app_number] => 15/663635
[patent_app_country] => US
[patent_app_date] => 2017-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 24
[patent_no_of_words] => 45594
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15663635
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/663635 | Genetically engineered gas vesicle gene clusters, genetic circuits, vectors, prokaryotic cells, compositions, methods and systems for contrast-enhanced imaging | Jul 27, 2017 | Issued |
Array
(
[id] => 13871489
[patent_doc_number] => 20190032085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => PROCESS FOR MIXING NUCLEIC ACIDS WITH TRANSFECTION REAGENTS FOR DELIVERY
[patent_app_type] => utility
[patent_app_number] => 15/661717
[patent_app_country] => US
[patent_app_date] => 2017-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15661717
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/661717 | Process for mixing nucleic acids with transfection reagents for delivery | Jul 26, 2017 | Issued |
Array
(
[id] => 14806203
[patent_doc_number] => 20190269711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => METHODS OF TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/320517
[patent_app_country] => US
[patent_app_date] => 2017-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23017
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320517
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320517 | Methods of treating cancer | Jul 23, 2017 | Issued |
Array
(
[id] => 12125130
[patent_doc_number] => 20180008716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'SOMATOSTATIN RECEPTOR-BASED CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/647840
[patent_app_country] => US
[patent_app_date] => 2017-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 29030
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 43
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15647840
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/647840 | Somatostatin receptor-based cancer therapy | Jul 11, 2017 | Issued |
Array
(
[id] => 14759547
[patent_doc_number] => 10391153
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of N-acetyl-aspartic acid
[patent_app_type] => utility
[patent_app_number] => 15/644313
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 7410
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15644313
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/644313 | Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of N-acetyl-aspartic acid | Jul 6, 2017 | Issued |
Array
(
[id] => 18642435
[patent_doc_number] => 11766488
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Compositions and methods comprising improvements of CRISPR guide RNAS using the H1 promoter
[patent_app_type] => utility
[patent_app_number] => 16/315458
[patent_app_country] => US
[patent_app_date] => 2017-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 77
[patent_figures_cnt] => 68
[patent_no_of_words] => 37436
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315458
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315458 | Compositions and methods comprising improvements of CRISPR guide RNAS using the H1 promoter | Jul 4, 2017 | Issued |
Array
(
[id] => 17286302
[patent_doc_number] => 11202840
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-21
[patent_title] => Modified dystrophin proteins
[patent_app_type] => utility
[patent_app_number] => 16/311236
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 21385
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311236
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311236 | Modified dystrophin proteins | Jun 20, 2017 | Issued |
Array
(
[id] => 17928487
[patent_doc_number] => 20220323612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => GENE THERAPY OF NEURONAL CEROID LIPOFUSCINOSES
[patent_app_type] => utility
[patent_app_number] => 16/309412
[patent_app_country] => US
[patent_app_date] => 2017-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309412
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309412 | GENE THERAPY OF NEURONAL CEROID LIPOFUSCINOSES | Jun 12, 2017 | Abandoned |
Array
(
[id] => 18683947
[patent_doc_number] => 11779657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Compositions and methods for mitochondrial genome editing
[patent_app_type] => utility
[patent_app_number] => 16/307128
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 31538
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307128
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/307128 | Compositions and methods for mitochondrial genome editing | Jun 8, 2017 | Issued |
Array
(
[id] => 12751414
[patent_doc_number] => 20180142305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => METHODS FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF PRIMARY AND METASTATIC BASAL-LIKE BREAST CANCER AND OTHER CANCER TYPES
[patent_app_type] => utility
[patent_app_number] => 15/617333
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15617333
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/617333 | Methods for diagnosis, prognosis and treatment of primary and metastatic basal-like breast cancer and other cancer types | Jun 7, 2017 | Issued |
Array
(
[id] => 16126479
[patent_doc_number] => 10696985
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-06-30
[patent_title] => Reversibly crosslinked endosomolytic polymer vesicles for cytosolic drug delivery
[patent_app_type] => utility
[patent_app_number] => 15/615753
[patent_app_country] => US
[patent_app_date] => 2017-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 38
[patent_no_of_words] => 9714
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15615753
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/615753 | Reversibly crosslinked endosomolytic polymer vesicles for cytosolic drug delivery | Jun 5, 2017 | Issued |
Array
(
[id] => 13566211
[patent_doc_number] => 20180334653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => TRANSGENIC MACROPHAGES, CHIMERIC ANTIGEN RECEPTORS, AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 15/597822
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15597822
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/597822 | Transgenic macrophages, chimeric antigen receptors, and associated methods | May 16, 2017 | Issued |
Array
(
[id] => 14324019
[patent_doc_number] => 10293002
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Methods and compositions for in vivo induction of pancreatic beta cell formation
[patent_app_type] => utility
[patent_app_number] => 15/595576
[patent_app_country] => US
[patent_app_date] => 2017-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 17698
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15595576
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/595576 | Methods and compositions for in vivo induction of pancreatic beta cell formation | May 14, 2017 | Issued |
Array
(
[id] => 11936756
[patent_doc_number] => 20170240907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'PRODUCTION OF RECOMBINANT EXPRESSION VECTORS'
[patent_app_type] => utility
[patent_app_number] => 15/590902
[patent_app_country] => US
[patent_app_date] => 2017-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8254
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15590902
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/590902 | Production of recombinant expression vectors | May 8, 2017 | Issued |
Array
(
[id] => 14621943
[patent_doc_number] => 20190224339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/097431
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 112463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -67
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097431
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097431 | COMPOSITIONS FOR THE TREATMENT OF DISEASE | Apr 27, 2017 | Abandoned |
Array
(
[id] => 11850127
[patent_doc_number] => 20170224618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'LIPOSOMAL COMPOSITIONS AND USES OF SAME'
[patent_app_type] => utility
[patent_app_number] => 15/498526
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 24957
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15498526
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/498526 | Liposomal compositions and uses of same | Apr 26, 2017 | Issued |
Array
(
[id] => 14388237
[patent_doc_number] => 10307374
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-04
[patent_title] => Oil-in-water emulsions that contain nucleic acids
[patent_app_type] => utility
[patent_app_number] => 15/495066
[patent_app_country] => US
[patent_app_date] => 2017-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 28533
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15495066
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/495066 | Oil-in-water emulsions that contain nucleic acids | Apr 23, 2017 | Issued |